-
The GDF15 Protein May Serve As A Biomarker For Identifying IPF Patients With Poor Outcomes
Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses a study that suggests how the GDF15 protein may serve as a biomarker for identifying IPF patients with poor outcomes.
Are you interested in learning more about Pulmonary Fibrosis? If so, please visit
pulmonaryfibrosisnews.com/What do you think about this news? Listen to this flash briefing episode and share your thoughts in the comment section below!
Sorry, there were no replies found.
Log in to reply.